Garcia et al. [187] evaluated the levels of ROS, GSH, and antioxidant enzyme activities in peripheral blood mononuclear cells, and CD4+ and CD8+ T-lymphocytes from patients with MASLD and control healthy subjects. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.